Back

Sacubitril/valsartan initiation among renin-angiotensin aldosterone system inhibitor-naive heart failure patients with reduced ejection fraction

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Heart failure prognosis and the options to improve Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor April Mohanty

University of Utah, Salt Lake City (United States of America)

14 More presentations in this session

Presentation thumbnail
The impact of anthropometric measures of obesity on heart failure outcomes in Asia
Doctor C. Chandramouli (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
S2PLIT Score: a simple risk score predicting post-discharge 1-year mortality in patients with acutely decompensated heart failure
Mr J. Borovac (Split, HR)
Abstract Slides Video
Presentation thumbnail
Increased all-cause mortality in newly diagnosed patients with heart failure between 2006 and 2012: a retrospective, population-based study in Sweden
Professor K. Lindmark (Umea, SE)
Presentation thumbnail
One year follow-up of heart failure patients: role of the new tnm-like classification
Doctor M. Pucci (Rome, IT)
Abstract Slides Video
Presentation thumbnail
High-dose loop diuretics are associated with adverse clinical outcomes in outpatients with chronic heart failure and mid-range and preserved ejection fraction: observations from the ESC Heart Failure
Doctor C. Kapelios (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure prognosis and the options to improve

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources